Pionyr Immunotherapeutics
Latest round
- Series B
Last raised
- Dec 2017
Total raised
- $46M
Investors
- 8
About Pionyr Immunotherapeutics
Pionyr Immunotherapeutics, Inc.Founded in 2015, Pionyr Immunotherapeutics, Inc. operates from San Francisco, US, developing advanced immunotherapies. The company was co-founded by Max Krummel, who has a history of founding pharmaceutical enterprises. In June 2020, Gilead Sciences, Inc.00 mn, leading to a full acquisition by Ikena Oncology, Inc. in August 2023.Pionyr Immunotherapeutics specializes in advanced therapeutic solutions aimed at addressing unmet medical needs within the biopharmaceutical sector. The company's core offerings focus on innovative treatments leveraging proprietary technologies to enhance the efficacy and safety of existing therapies.Pionyr Immunotherapeutics generates revenue through partnerships with healthcare institutions and direct sales to specialized clinics. Their revenue model includes long-term agreements for the distribution of flagship therapeutic products and a subscription-based model for certain services, ensuring continuous access to their therapies.The recent acquisition by Ikena Oncology will allow Pionyr Immunotherapeutics to bolster its targeted oncology programs and potentially introduce new products aimed at addressing cancer treatment. The specific upcoming product launches and timelines are not disclosed. The company plans to expand its market presence further, particularly focusing on oncology sectors in North America and Europe.
Who invested in Pionyr Immunotherapeutics
8 investors across 2 rounds
See all investors in Pionyr Immunotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pionyr Immunotherapeutics
Who invested in Pionyr Immunotherapeutics?
Pionyr Immunotherapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pionyr Immunotherapeutics raised?
Pionyr Immunotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pionyr Immunotherapeutics last raise money?
Pionyr Immunotherapeutics's most recent round on record is a Series B, in Dec 2017.
What does Pionyr Immunotherapeutics do?
Pionyr Immunotherapeutics, Inc.
Where is Pionyr Immunotherapeutics headquartered?
Pionyr Immunotherapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Pionyr Immunotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pionyr Immunotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pionyr Immunotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.